AngioDynamics, Inc. (ANGO)
15.87
-0.26
(-1.61%)
USD |
NASDAQ |
Sep 01, 16:00
15.87
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Free Cash Flow : -2.86M for May 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| May 31, 2026 | -2.86M |
| February 28, 2026 | -3.534M |
| November 30, 2025 | -15.26M |
| August 31, 2025 | -17.79M |
| May 31, 2025 | -20.99M |
| February 28, 2025 | -37.07M |
| November 30, 2024 | -37.11M |
| August 31, 2024 | -32.91M |
| May 31, 2024 | -38.94M |
| February 29, 2024 | -28.11M |
| November 30, 2023 | -11.56M |
| August 31, 2023 | -9.558M |
| May 31, 2023 | -9.668M |
| February 28, 2023 | -23.81M |
| November 30, 2022 | -33.87M |
| August 31, 2022 | -39.78M |
| May 31, 2022 | -22.90M |
| February 28, 2022 | -15.96M |
| November 30, 2021 | -1.571M |
| August 31, 2021 | 7.706M |
| May 31, 2021 | 10.38M |
| February 28, 2021 | 9.728M |
| November 30, 2020 | -13.60M |
| August 31, 2020 | -20.57M |
| May 31, 2020 | -22.14M |
| Date | Value |
|---|---|
| February 29, 2020 | -0.343M |
| November 30, 2019 | 25.95M |
| August 31, 2019 | 35.06M |
| May 31, 2019 | 34.32M |
| February 28, 2019 | 33.15M |
| November 30, 2018 | 29.59M |
| August 31, 2018 | 26.81M |
| May 31, 2018 | 38.90M |
| February 28, 2018 | 34.12M |
| November 30, 2017 | 44.18M |
| August 31, 2017 | 48.32M |
| May 31, 2017 | 52.74M |
| February 28, 2017 | 49.34M |
| November 30, 2016 | 47.05M |
| August 31, 2016 | 42.62M |
| May 31, 2016 | 39.62M |
| February 29, 2016 | 34.33M |
| November 30, 2015 | 30.63M |
| August 31, 2015 | 16.81M |
| May 31, 2015 | 12.95M |
| February 28, 2015 | 9.477M |
| November 30, 2014 | -0.911M |
| August 31, 2014 | 8.701M |
| May 31, 2014 | 12.07M |
| February 28, 2014 | 12.80M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.625B |
| Penumbra, Inc. | 215.91M |
| Abbott Laboratories | 7.824B |
| Alphatec Holdings, Inc. | -5.739M |
| AtriCure, Inc. | 53.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 17.45M |
| Cash from Investing (Quarterly) | -1.27M |
| Cash from Financing (Quarterly) | -0.108M |
| Free Cash Flow Per Share (Quarterly) | 0.3881 |
| Free Cash Flow to Equity (Quarterly) | 16.62M |
| Free Cash Flow to Firm (Quarterly) | 16.29M |
| Free Cash Flow Yield | -0.43% |